You are here: EnoGene Home > Products > Pathological (Immunohistochemistry, IHC) antibodies > CDK5 (2E8) Mouse mAb

CDK5 (2E8) Mouse mAb
Datasheet   

  • Catalog Number:

    E2200543

  • Amount:

    100ul

  • Source:

    Mouse

  • Form of Antibody:

    Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide, pH 7.3.

  • Specificity/Sensitivity:

    This antibody detects endogenous levels CDK5(N-terminus) and does not cross-react with related proteins.

  • Entrez summary:

    Cdks (cyclin-dependent kinases) are heteromeric serine/threonine kinases that control progression through the cell cycle in concert with their regulatory subunits, the cyclins. Although there are 12 different cdk genes, only 5 have been shown to directly drive the cell cycle (Cdk1, -2, -3, -4, and -6). Following extracellular mitogenic stimuli, cyclin D gene expression is upregulated. Cdk4 forms a complex with cyclin D and phosphorylates Rb protein, leading to liberation of the transcription factor E2F. E2F induces transcription of genes including cyclins A and E, DNA polymerase and thymidine kinase. Cdk4-cyclin E complexes form and initiate G1/S transition. Subsequently, Cdk1-cyclin B complexes form and induce G2/M phase transition. Cdk1-cyclin B activation induces the breakdown of the nuclear envelope and the initiation of mitosis. Cdks are constitutively expressed and are regulated by several kinases and phosphastases, including Wee1, CDK-activating kinase and Cdc25 phosphatase. In addition, cyclin expression is induced by molecular signals at specific points of the cell cycle, leading to activation of Cdks. Tight control of Cdks is essential as misregulation can induce unscheduled proliferation, and genomic and chromosomal instability. Cdk4 has been shown to be mutated in some types of cancer, whilst a chromosomal rearrangement can lead to Cdk6 overexpression in lymphoma, leukemia and melanoma. Cdks are currently under investigation as potential targets for antineoplastic therapy, but as Cdks are essential for driving each cell cycle phase, therapeutic strategies that block Cdk activity are unlikely to selectively target tumor cells.

  • UniPort summary Function:

    Probably involved in the control of the cell cycle. Interacts with D1 and D3-type G1 cyclins. Can phosphorylate histone H1, tau, MAP2 and NF-H and NF-M. Also interacts with p35 which activates the kinase.

  • Immunogen:

    Purified recombinant human CDK5(N-terminus) protein fragments expressed in E.coli.

  • Antibody type:

    Monoclonal Antibody

  • Isotype:

    IgG1

  • Purification:

    Affinity Purified

  • Cellular localization:

    Cytoplasm. Cell membrane; Peripheral membrane protein. Perikaryon. Cell projection

  • Reactivity:

    Human,Mouse,Rat,Monkey

  • Applications:

    WB,ICC/IF

  • Molecular Weight:

    Calculated MW: 33 kDa; Observed MW: 36 kDa

  • UniProt Number:

    Q00535

  • Gene ID:

    1020

  • Gene symbol:

    PSSALRE

  • Altername:

    Cdk 5; Cdk5; CDK5_HUMAN; Cell division protein kinase 5; Crk6; Cyclin dependent kinase 5; Cyclin-dependent kinase 5; Protein kinase CDK5 splicing; PSSALRE; Serine threonine protein kinase PSSALRE; Serine/threonine-protein kinase PSSALRE; Tau protein kinase II catalytic subunit; TPKII catalytic subunit.

  • Western blot analysis of CDK5(Nterminus) in 3T3, Hela, PC-12, COS7, Jurkat and K562
    lysates using Cdk5 antibody

  • Immunocytochemistry analysis of CDK5 in HeLa cells using CDK5 antibody

  • Price:

    255$

  • Research Area:

    Autophagy antibody Cancer Cardiovascular Cell Biology Epigenetics & Nuclear Signaling Developmental Biologys Immunology Drug Discovery Products Metabolism Neuroscience Signal Transduction Stem Cells

  • Product Type:

    Primary Antibody

  • Background:

    Activated by cyclins but by p35 (CDK5R1) and p39. An important regulator of neuronal positioning during brain development. May also play a role in synaptogenesis and neurotransmission. Substrates include TAU, MAP2, NF-H and -M, Nudel, PDE6, beta-catenin, amphyphysin, dynamin I, synapsin 1, Munc-18, and NMDA receptor 2A. Plays a role in myogenesis, haematopoietic cell differentiation, spermatogenesis, insulin secretion, and lens differentiation.

  • Clone Number:

    2E8-F9-B7-C11

  • Gene Name:

    CDK5

  • Recommended Dilutions:

    WB: 1/500-1/1000 IF: 1/50-1/200

  • Swiss-Prot No.:

    Q00535

  • Storage/Stability:

    Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.

Add to Cart

Related Products

c-Jun (Phospho-Ser63) Antibody
c-Jun (Phospho-Ser63) Antibody Datasheet  COA   

  • Catalog Number:

    E011001-1

  • Amount:

    50μg/50μl

  • Reactivity:

    Human, Mouse

  • Applications:

    WB: 1:500~1:1000 IHC: 1:50~1:100

  • Swiss-Prot No.:

    P05412

  • Price:

    145$
  • Add to Cart
c-Jun (Phospho-Ser63) Antibody
c-Jun (Phospho-Ser63) Antibody Datasheet  

  • Catalog Number:

    E011001-2

  • Amount:

    100μg/100μl

  • Reactivity:

    Human, Mouse

  • Applications:

    WB: 1:500~1:1000 IHC: 1:50~1:100

  • Swiss-Prot No.:

    P05412

  • Price:

    225$
  • Add to Cart
Rb Polyclonal Antibody
Rb Polyclonal Antibody Datasheet  

  • Catalog Number:

    E90003

  • Amount:

    100ul

  • Reactivity:

    H M

  • Applications:

    WB IHC

  • Swiss-Prot No.:

    P06400

  • Price:

    225$
  • Add to Cart
Elk-1 (Phospho-Ser383) Antibody
Elk-1 (Phospho-Ser383) Antibody Datasheet  

  • Catalog Number:

    E011004-1

  • Amount:

    50μg/50μl

  • Reactivity:

    Human, Mouse, Rat

  • Applications:

    WB: 1:500~1:1000 IHC: 1:50~1:100

  • Swiss-Prot No.:

    P19419

  • Price:

    145$
  • Add to Cart
Elk-1 (Phospho-Ser383) Antibody
Elk-1 (Phospho-Ser383) Antibody Datasheet  

  • Catalog Number:

    E011004-2

  • Amount:

    100μg/100μl

  • Reactivity:

    Human, Mouse, Rat

  • Applications:

    WB: 1:500~1:1000 IHC: 1:50~1:100

  • Swiss-Prot No.:

    P19419

  • Price:

    225$
  • Add to Cart

Catalog Number

  • Amount:100ul
  • Price:255$

Add to Cart

AbPromise

Contact us